Fintech Firm Blend Labs Seeks US$360 Million In IPO

Blend Labs Inc. announced this morning the launch of its initial public offering on the New York Stock Exchange. The company will be offering 20.0 million Class A stocks on the big board under the symbol “BLND”.

The offering price is expected to be between US$16.00 to US$18.00 per share for potential total aggregate proceeds of up to US$360.0 million. The financial software company also gave the underwriters a 30-day option to purchase an additional 3,000,000 common shares.

In the prospectus filed, the San Francisco-based fintech company recorded US$31.9 million in revenue and a US$27.1 million net loss for Q1 2021. The company also raised US$300.0 million in its last round of funding in January 2021, putting the company’s valuation at US$3.3 billion. The proposed public offering seeks to bring this up to US$3.95 billion.

Goldman Sachs & Co., Allen & Company, and Wells Fargo Securities are all managing the offering as lead underwriters. 


Information for this briefing was found via Blend. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Agnico Q1 Earnings Results Overshadowed By A Sinking Gold Price

Why More People Are Starting to Feel Broke | Darrell Thomas – VRIC Media

Newmont Q1 Earnings: A Billion In Free Cash Flow… A Month!

Recommended

Selkirk Copper Strikes New Lens Beneath Old Pit, Launches 50,000 Metre Phase 2 Program

Silver47 Pulls High-Grade Gold and Silver Assays from Nevada Vein Network At Kennedy

Related News

Coinbase: The IPO Deep Dive

Coinbase Global (NASDAQ: COIN) is one of the hottest deals coming to market in 2021...

Tuesday, April 13, 2021, 01:30:00 PM

Wellness Firm The Better Being Co. Launches US$213 Million IPO

Whole-body wellness enterprise The Better Being Co. announced today the launch of its initial public...

Monday, July 26, 2021, 11:30:00 AM

Biotech Firm PepGen Prices US$108 Million IPO

Biopharmaceutical company PepGen, Inc. (Nasdaq: PEPG) began trading on the Nasdaq Global Select Market on...

Monday, May 9, 2022, 02:27:00 PM

Hemp Manufacturer Hempacco Prices Downsized US$6 Million IPO

Hemp manufacturing company Hempacco Co., Inc. (Nasdaq: HPCO) started trading its shares on the Nasdaq...

Tuesday, August 30, 2022, 02:19:00 PM

Oncology Firm TransCode Therapeutics Looks To Raise US$25 Million In IPO

Oncology company TransCode Therapeutics, Inc. is set to begin publicly trading its equityon the Nasdaq...

Friday, July 9, 2021, 09:53:00 AM